40.00

Content Details
Information on this page was last modified on : 2021/04/28 12:43:30 PM

Mini BC 8.40% Infusion 1 Ampx50 mL

Mini BC Infusion contains Sodium Bicarbonate, Inj | belongs to

Alternate brands of Mini BC 8.40% Infusion 1 Ampx50 mL

Brand Name Price Savings
Sodium Bicarbonate 8.40% Infusion 1 Vialx50 mL  37.29 You can save 2.71
Sobonate Bicarbonate 8.40% Infusion 1 Ampx20 mL  15.00 You can save 25
Sobicarb 8.40% Infusion 1 Ampx20 mL  15.30 You can save 24.7
Mini BC 8.40% Infusion 1 Ampx25 mL  16.00 You can save 24
Mini BC 8.40% Infusion 1 Ampx20 mL  15.00 You can save 25
List of alternate brands

How it works

As an antacid, this medicine helps in neutralizing stomach acid during indigestion and heartburn. It acts as a buffer against an excess acidic condition of the body by raising blood pH. It increases the urinary pH by increasing the excretion of free bicarbonate ions in the urine.

Side effects

Major & minor side effects for Mini BC 8.40% Infusion 1 Ampx50 mL

  • Headache
  • Nausea or Vomiting
  • Muscle pain or twitching
  • Slow breathing
  • Increased thirst
  • Stomach cramps
  • Frequent urge to urinate
  • Loss of appetite
  • Unpleasant taste
  • Mood or mental changes
  • Unsual tiredness or weakness
  • Dry mouth

Uses of Mini BC 8.40% Infusion 1 Ampx50 mL

What is it prescribed for?

  • Metabolic Acidosis

    This medicine is used in the treatment of an excess acidic condition of the body resulting from many clinical conditions such as severe dehydration, kidney insufficiency, severe diarrhea, heart problems, etc.

  • Diabetic ketoacidosis

    This medicine is used in the treatment of a diabetes complication called Diabetic ketoacidosis, a condition of a buildup of acids (ketones) in the blood.

  • Urine alkalinization

    This medicine is used for urine alkalinization which helps to increase excretion of toxic substances from the kidneys.

  • Dyspepsia

    This medicine is used to treat indigestion.

  • Hyperkalemia

    This medicine is used to correct the blood potassium levels in patients with hyperkalemia (Increased blood potassium levels).

  • Asystole

    This medicine is used for the treatment of the most serious form of cardiac arrest where the electrical activity stops or pauses.

Concerns

Frequently asked questions

  • Onset of action

    Parenteral form: The effect of this medicine can be observed within 15 minutes on an intravenous administration of the dose. Oral form: The amount of time taken by this medicine to show its effect is subject to vary based on the individual, strength, and form of administration.

  • Duration of Effect

    Parenteral form: The effect of this medicine lasts for an average duration of 1 to 2 hours after an intravenous administration of the dose. Oral form: The amount of time for which this medicine remains effective is subject to vary based on the individual, strength, and form of administration.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Mini BC 8.40% Infusion 1 Ampx50 mL or any other inactive ingredients present along with it.

  • Metabolic or respiratory alkalosis

    This medicine is not recommended for use when the patient with metabolic or respiratory alkalosis due to the risk of worsening of the patient's condition.

  • Hypocalcemia

    This medicine is not recommended for use in patients with hypocalcemia (low levels of calcium in the blood) due to the risk of worsening of the patient's condition.

  • Hypochloremia

    This medicine is not recommended for use in patients with excessive chloride loss by vomiting or gastrointestinal suctioning due to the risk of worsening of the patient's condition.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

General Warnings
  • Electrolytes and acid-base status

    It is recommended to monitor the electrolyte levels and acid-base status during and completion of therapy with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Sodium and water retention

    This medicine can induce sodium and water retention and hence should be used with extreme caution in patients with hypernatremia (increased blood sodium levels) or fluid retention due to the risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Hypokalemia

    This medicine may lower the blood potassium levels in some patients. Close monitoring of the blood potassium levels is necessary while receiving this medicine. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Kidney impairment

    This medicine should be used with extreme caution in patients with kidney impairment due to the risk of worsening of the patient's condition. Close monitoring of kidney function is recommended while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases.

  • Stomach disorders

    This medicine should be used with extreme caution in patients with stomach disorders due to the risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Liver impairment

    This medicine should be used with extreme caution in patients with liver impairment due to the risk of worsening of the patient's condition. Close monitoring of liver function is recommended while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases.

  • Other uses

    Your doctor may prescribe this medicine for indications other than those stated above in certain specific circumstances, especially if other medicines are not effective. All the risks and benefits should be discussed with the doctor in such cases.

Dosage

  • Missed Dose

    Oral Form: Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Parenteral Form: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

  • Overdose

    Oral Form: Seek emergency medical treatment or contact the doctor in case of an overdose. Parenteral Form: Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Interaction with Medicines
  • Bisacodyl moderate
  • Dolutegravir severe
  • Glipizide moderate

General Instructions

Oral Form: Take this medicine exactly as prescribed by the doctor. Do not take in larger or smaller quantities than recommended. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor. Parenteral Form: This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

Other details

  • Can be taken with or without food, as advised by your doctor
  • To be taken as instructed by doctor
  • Effect on sleep is not established

References

Additional Information:

How to use Mini BC 8.40% Infusion 1 Ampx50 mL

For direct IV administration: in neonates & infants, use the 0.5 mEq/ mL solution or dilute the 1 mEq/ mL solution 1:1 with sterile Water for Injection. In children & adults, the 1 mEq/ mL solution may be used. Administer slowly (maximum rate in neonates & infants: 10 mEq/min); for infusion, dilute to a maximum concentration of 0.5 mEq/ mL in dextrose solution and infuse over 2 hours (maximum rate of administration: 1 mEq/kg/hour).

What happens if I miss a dose of Mini BC 8.40% Infusion 1 Ampx50 mL?

Cardiac arrest: Infants: 1 mEq/kg slow IVP initially; may repeat with 0.5 mEq/kg in 10 min one time, or as indicted by patients acid-base status. Children & Adults: 1 mEq/kg IVP initially; may repeat with 0.5 mEq/kg in 10 min one time, or as indicted by patients acid-base status.
Metabolic acidosis: Dosage should be based on the following formula if blood gases & pH measurements are available: Neonates, infants & children: HCO3 (mEq) = 0.3 x weight (kg) x base deficit (mEq/L) or HCO3 (mEq) = 0.5 x weight (kg) x [24 – serum HCO3 (mEq)]. Adults: HCO3 (mEq) = 0.2 x weight (kg) x base deficit (mEq/L) or HCO3 (mEq) = 0.5 x weight (kg) x [24 – serum HCO3 (mEq)]. If acid-base status is not available: Dose for older children & Adults: 2-5 mEq/kg IV infusion over 4-8 hr; subsequent doses should be based on patients acid-base status.

One of the following licensed pharmacy from the nearest location will deliver Mini BC 8.40% Infusion 1 Ampx50 mL. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “Mini BC 8.40% Infusion 1 Ampx50 mL”
Shopping Cart